Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia

Front Cell Infect Microbiol. 2022 Aug 18:12:934671. doi: 10.3389/fcimb.2022.934671. eCollection 2022.

Abstract

Pneumonia is one of the leading causes of morbidity and mortality worldwide and Gram-negative bacteria are a major cause of severe pneumonia. Despite advances in diagnosis and treatment, the rise of multidrug-resistant organisms and hypervirulent strains demonstrates that there will continue to be challenges with traditional treatment strategies using antibiotics. Hence, an alternative approach is to focus on the disease tolerance components that mediate immune resistance and enhance tissue resilience. Adaptive immunity plays a pivotal role in modulating these processes, thus affecting the incidence and severity of pneumonia. In this review, we focus on the adaptive T cell responses to pneumonia induced by Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. We highlight key factors in these responses that have potential for therapeutic targeting, as well as the gaps in current knowledge to be focused on in future work.

Keywords: T cells; adaptive immunity; gram-negative pneumonia; host – bacteria interaction.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii*
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria
  • Humans
  • Microbial Sensitivity Tests
  • Pneumonia, Bacterial* / drug therapy
  • Pseudomonas aeruginosa
  • T-Lymphocytes

Substances

  • Anti-Bacterial Agents